Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of TAK-169 in Participants With Relapsed or Refractory Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04017130
Recruitment Status : Recruiting
First Posted : July 12, 2019
Last Update Posted : March 26, 2021
Sponsor:
Information provided by (Responsible Party):
Takeda

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 17, 2023
Estimated Study Completion Date : January 17, 2023